MaxCyte, Inc. - Common Stock (NQ:MXCT)
0.8701
+0.0541
(+6.63%)
Streaming Delayed Price
Updated: 3:06 PM EST, Feb 4, 2026
Add to My Watchlist
Press Releases about MaxCyte, Inc. - Common Stock
MaxCyte Announces Planned CFO Transition in 2026
November 12, 2025
From MaxCyte, Inc
Via GlobeNewswire
From MaxCyte, Inc
Via GlobeNewswire
MaxCyte Signs Platform License Agreement with Adicet Bio
August 04, 2025
From MaxCyte, Inc
Via GlobeNewswire
From MaxCyte, Inc
Via GlobeNewswire
From MaxCyte, Inc
Via GlobeNewswire
From MaxCyte, Inc
Via GlobeNewswire
MaxCyte Announces Retirement of Board Member Art Mandell
December 23, 2024
From MaxCyte, Inc
Via GlobeNewswire
From MaxCyte, Inc
Via GlobeNewswire
MaxCyte Reports Third Quarter 2024 Financial Results and Updates Full Year 2024 Guidance
November 06, 2024
From MaxCyte, Inc
Via GlobeNewswire
MaxCyte to Participate in Two Upcoming Investor Conferences
October 31, 2024
From MaxCyte, Inc
Via GlobeNewswire
MaxCyte Appoints Cynthia Collins to its Board of Directors
October 15, 2024
From MaxCyte, Inc
Via GlobeNewswire
From MaxCyte, Inc
Via GlobeNewswire
MaxCyte Appoints Ali Soleymannezhad as Chief Commercial Officer
October 10, 2024
From MaxCyte, Inc
Via GlobeNewswire
MaxCyte to Participate in Virtual Craig-Hallum Capital Group Bioprocessing Conference
September 05, 2024
From MaxCyte, Inc
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
>